Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

SCHERING-PLOUGH CORPORATION;PATENT DEPARTMENT (K-6-1, 1990)

KENILWORTH, NJ US

1. 20100098661 4,5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS 04-22-2010
2. 20100095963 PHARMACEUTICAL COMPOSITIONS - Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and processes for 04-22-2010
3. 20100093695 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors 04-15-2010
4. 20100093692 PIPERIDINYL-PIPERIDINE AND PIPERAZINYL-PIPERIDINE FOR USE IN THE TREATMENT OF DIABETES OR PAIN 04-15-2010
5. 20100093630 MAMMALIAN CHEMOKINES; RELATED REAGENTS - Novel CC chemokines from human reagents related thereto including purified proteins specific antibodies and 04-15-2010
6. 20100087499 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING TEMOZOLOMIDE AND MULTI-TARGETED KINASE INHIBITORS 04-08-2010
7. 20100087425 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors 04-08-2010
8. 20100087409 COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID 04-08-2010
9. 20100086560 CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE 04-08-2010
10. 20100083964 DISPENSER DOSE COUNTER MECHANISM - apparatus for counting doses of a dispenser is provided which includes a housing for releasably attaching to the 04-08-2010
11. 20100083534 MULTILAYER LAMINATE FOOTWEAR INSOLE - with a top layer and a bottom layer with at least one cushioning layer 04-08-2010
12. 20100081672 PH SENSITIVE MATRIX FORMULATION - formulations of therapeutic agents that benefit from a prolonged time of controlled release in the stomach and upper 04-01-2010
13. 20100075415 METHOD FOR REDUCING PROTEASE ACTIVITY IN PLANT HYDROLYSATE 03-25-2010
14. 20100074867 P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE 03-25-2010
15. 20100069406 ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of formula I Formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or 03-18-2010
16. 20100068763 MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES 03-18-2010
17. 20100068280 SUSTAINED RELEASE PHARMACEUTICAL DOSAGE FORM CONTAINING PHENYLEPHRINE 03-18-2010
18. 20100068181 PYRROLO [3, 2-A] PYRIDINE DERIVATIVES FOR INHIBITING KSP KINESIN ACTIVITY 03-18-2010
19. 20100063280 PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS 03-11-2010
20. 20100063121 Macrocyclic Heterocyclic Aspartyl Protease Inhibitors 03-11-2010
21. 20100055090 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS 03-04-2010
22. 20100048601 HYDROCHLORIDE SALTS OF 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one AND PREPARATION PROCESS THEREFOR 02-25-2010
23. 20100036125 SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS - the synthesis of 4-[4-[-[1-[cyclopropylsulfonyl)-4-piperidinyl]methyl]-- 02-11-2010
24. 20100029939 PREPARATION OF KETONE AMIDES - novel process to prepare ketone amides which are useful intermediates for the preparation of antagonists of CCR5 receptor 02-04-2010
25. 20100029607 Substituted Piperazines as CB1 Antagonists 02-04-2010
26. 20100022577 DRY SYRUP CONTAINING LORATADINE - Dry syrup preparations comprising loratadine as a hydrophobic medicinal drug are provided 01-28-2010
27. 20100022493 USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE 01-28-2010
28. 20100016341 ASPARTYL PROTEASE INHIBITORS CONTAINING A TRICYCLIC RING SYSTEM 01-21-2010
29. 20100015182 COCCIDIOSIS VACCINES - vaccine that provides protection from coccidiosis and methods of making and using the vaccine alone 01-21-2010
30. 20100015132 USES OF MAMMALIAN CYTOKINES AND AGONISTS; RELATED REAGENTS 01-21-2010
31. 20100008948 RECOMBINANT HERPESVIRUS USEFUL IN VACCINE PRODUCTION 01-14-2010
32. 20100008889 ADENOVIRAL EXPRESSION VECTORS - recombinant adenovirus vector characterized by the partial or total deletion of adenoviral E2B function and having an 01-14-2010
33. 20100004647 CRYOSURGERY DEVICE - includes an aerosol container holding a liquid refrigerant and having a valve and a stem extending out therefrom 01-07-2010
34. 20090326244 BISULFITE PURIFICATION OF AN ALPHA-KETO AMIDE 12-31-2009
35. 20090326241 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES 12-31-2009
36. 20090320324 CUSHIONING DEVICE - comprising a sticky surface the device comprising a gel material bound to a thermoplastic film material having a polarity compatible 12-31-2009
37. 20090317398 MAMMALIAN CX3C CHEMOKINE ANTIBODIES - Nucleic acids encoding a new family of chemokines the CX3C family from a mammal 12-24-2009
38. 20090312576 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 3-(AMINO)-3-CYCLOBUTYLMETHYL-2-HYDROXY-PROPIONAMIDE OR SALTS THEREOF 12-17-2009
39. 20090312341 CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT 12-17-2009
40. 20090311282 NEUTRALIZING GDF8 EPITOPE-BASED GROWTH ENHANCING VACCINE 12-17-2009
41. 20090306079 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS 12-10-2009
42. 20090306047 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS 12-10-2009
43. 20090298802 Pharmaceutical Compositions - Disclosed are inhalable medicaments and methods based on an anticholinergic in combination with a corticosteroid 12-03-2009
44. 20090294288 High-sensitivity proteolysis assay - The present invention includes a highly sensitive method for detecting the presence of proteases in a sample which 12-03-2009
45. 20090286830 HETEROATOM-LINKED SUBSTITUTED PIPERIDINES AND DERIVATIVES THEREOF USEFUL AS HISTAMINE H3 ANTAGONISTS 11-19-2009
46. 20090285779 INDUCTION OF APOPTOSIS IN TOLL-LIKE RECEPTOR EXPRESSING TUMOR CELLS 11-19-2009
47. 20090281321 EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS 11-12-2009
48. 20090281156 ENHANCING PHOTOSTABILIZATION OF OXYMETAZOLINE 11-12-2009
49. 20090280160 PHENYLEPHRINE PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION 11-12-2009
50. 20090275735 MONOCLONAL ANTIBODIES TO HUMAN CTLA-8 (IL-17A) 11-05-2009
51. 20090275135 MAMMALIAN CYTOKINES; RECEPTORS; RELATED REAGENTS AND METHODS 11-05-2009
52. 20090274724 NOVEL RECOMBINANT AND MUTANT ADENOVIRUSES 11-05-2009
53. 20090270432 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(- 1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5-AMINE 10-29-2009
54. 20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE 10-22-2009
55. 20090258868 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS 10-15-2009
56. 20090247784 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF (1R,2S,5S)-6,6-DIMETHYL-3-AZABICYCLO[3,1,0]HEXANE-2-CARBOXYLATES OR SALTS THEREOF 10-01-2009
57. 20090247599 METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE 10-01-2009
58. 20090247598 TREATMENT METHODS - There are disclosed methods for treating cancer in a patient in need of such treating comprising administering temozolomide 10-01-2009
59. 20090240063 Process For The Preparation Of 6,6-Dimethyl-3-Azabicyclo-[3.1.0]-Hexane Compounds ... 09-24-2009
60. 20090239890 SPIRO SUBSTITUTED CYCLOPROPANE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 09-24-2009
61. 20090238771 PHARMACEUTICAL FORMULATIONS - aspect of the present invention provides for a medicament including a solution containing pleconaril or a pharmaceutically 09-24-2009
62. 20090232754 ENHANCED PHOTOSTABILITY OF SUNCARE COMPOSITIONS CONTAINING AVOBENZONE 09-17-2009
63. 20090221541 PHARMACEUTICAL FORMULATIONS - aspect of the present invention provides for a medicament suitable for administration as a nasal inhalant including an 09-03-2009
64. 20090221016 MODIFIED TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AND METHODS OF USE THEREOF 09-03-2009
65. 20090220457 COMBINATIONS COMPRISING HCV PROTEASE INHIBITOR(S) AND HCV IRES INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO 09-03-2009
66. 20090209483 TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION 08-20-2009
67. 20090208522 Neutralizing Epitope-Based Growth Enhancing Vaccine 08-20-2009
68. 20090203936 SYNTHESIS OF 3-(5-NITROCYCLOHEX-1-ENYL) ACRYLIC ACID AND ESTERS THEREOF 08-13-2009
69. 20090203925 SYNTHESIS OF HIMBACINE ANALOGS - improved process for preparing himbacine analogs 08-13-2009
70. 20090192178 mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS 07-30-2009
71. 20090191629 MAMMALIAN CHEMOKINE REAGENTS - Novel chemokines from mammals reagents related thereto including purified proteins specific antibodies 07-30-2009
72. 20090191239 RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF 07-30-2009
73. 20090189090 METHOD OF SELECTING ANTIOXIDANTS FOR USE IN TOPICALLY APPLIED COMPOSITIONS 07-30-2009
74. 20090176852 PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS 07-09-2009
75. 20090176254 MAMMALIAN GALANIN RECEPTORS - isolated mammalian GalR3 receptors isolated or recombinant nucleic acids and recombinant vectors encoding the same 07-09-2009
76. 20090175881 ANTIBODIES TO IL-17A - Engineered antibodies to human IL-17A are provided, as well as uses thereof 07-09-2009
77. 20090175877 METHODS OF INHIBITING METASTASIS - or maintenance of various cancers are provided 07-09-2009
78. 20090175852 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS 07-09-2009
79. 20090170875 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 07-02-2009
80. 20090170861 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors 07-02-2009
81. 20090162443 COMPOSITIONS AND METHODS FOR REDUCING OR PREVENTING WATER LOSS FROM THE SKIN 06-25-2009
82. 20090162391 VACCINE ANTIGENS FROM PISCIRICKETTSIA SALMONIS 06-25-2009
83. 20090159544 MEDICINE BOTTLE WITH GRIP - bottle for a medicine is disclosed 06-25-2009
84. 20090156683 FAST RELEASE SOLID FORMULATION, PREPARATION AND USE THEREOF 06-18-2009
85. 20090156586 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 06-18-2009
86. 20090155194 ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS 06-18-2009
87. 20090149480 METHODS OF USING PDE V INHIBITORS FOR THE TREATMENT OF CONGESTIVE HEART FAILURE 06-11-2009
88. 20090148456 CANINE RANKL AND METHODS FOR PREPARING AND USING THE SAME 06-11-2009
89. 20090137586 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 05-28-2009
90. 20090137575 Fused Tetracyclic mGluR1 Antagonists as Therapeutic Agents 05-28-2009
91. 20090131663 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES 05-21-2009
92. 20090118284 Novel compounds that are ERK inhibitors - Disclosed are the ERK inhibitors of formula 1 05-07-2009
93. 20090111831 PHARMACEUTICAL COMPOSITIONS - Disclosed herein are novel compositions useful for the treatment of androgen dependant diseases 04-30-2009
94. 20090111803 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS 04-30-2009
95. 20090105282 METHODS OF TREATING BENIGN PROSTATIC HYPERPLASIA OR LOWER URINARY TRACT SYMPTOMS BY USING PDE 5 INHIBITORS 04-23-2009
96. 20090105248 3-MONOSUBSTITUTED TROPANE DERIVATIVES AS NOCICEPTIN RECEPTOR LIGANDS 04-23-2009
97. 20090105208 Substituted Piperazines as CB1 Antagonists 04-23-2009
98. 20090098128 NPC1L1 orthologues - The present invention provides, in part, NPC1L1 from various species 04-16-2009
99. 20090098070 SUNSCREEN COMPOSITIONS WITH LOW EYE-STING AND HIGH SPF 04-16-2009
100. 20090093496 PREPARATION OF PHARMACEUTICAL SALTS OF PIPERAZINE COMPOUNDS 04-09-2009
101. 20090092597 MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS 04-09-2009
102. 20090087394 PHOTOSTABILIZATION OF OCTYL TRIAZONE - Methods and compositions useful in enhancing protection from UV radiation the compositions containing octyl 04-02-2009
103. 20090082336 mGluR1 Antagonists as Therapeutic Agents 03-26-2009
104. 20090081706 CRYSTALLINE FORM OF THE CATALYTIC DOMAIN OF AURORA 2 KINASE AND METHODS OF USE THEREOF 03-26-2009
105. 20090076088 Thrombin Receptor Antagonists - series of compounds represented by the structural formulas STR00001 STR00002 and pharmaceutically acceptable isomers 03-19-2009
106. 20090075297 MAMMALIAN GALANIN RECEPTORS - isolated mammalian GalR3 receptors isolated or recombinant nucleic acids and recombinant vectors encoding the same 03-19-2009
107. 20090074869 PHARMACEUTICAL FORMULATIONS - Disclosed are pharmaceutically acceptable PDE V inhibitor Formulations that are especially useful for treating male 03-19-2009
108. 20090069383 Thrombin Receptor Antagonists - series of compounds represented by the structural formulas STR00001 STR00002 and pharmaceutically acceptable isomers 03-12-2009
109. 20090062239 THROMBIN RECEPTOR ANTAGONISTS AS PROPHYLAXIS TO COMPLICATIONS FROM CARDIOPULMONARY SURGERY 03-05-2009
110. 20090057189 CONTAINER FOR TRANSPORTING A BLISTER PACKAGE 03-05-2009
111. 20090048458 SYNTHESIS OF 2-HYDROXY-N,N-DIMETHYL-3-[[2-[[1(R)-(5-METHYL-2-FURANYL)PROPYL]AMINO]-3,4- -DIOXO-1-CYCLOBUTEN-1-YL]AMINO]BENZAMIDE 02-19-2009
112. 20090041771 Immunological methods and compositions for the treatment of Alzheimer's disease 02-12-2009
113. 20090031583 Foot Support For Alleviating Knee Pain - foot support is disclosed 02-05-2009
114. 20090029967 ADENOSINE A2A RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS 01-29-2009
115. 20090023919 SYNTHESIS OF TEMOZOLOMIDE AND ANALOGS - This invention relates to a novel process for the synthesis of Temozolomide an antitumor compound 01-22-2009
116. 20090022671 TREATMENT METHODS - Disclosed are methods of treating rhinosinusitis of the upper airway passages in patients afflicted with said disease 01-22-2009
117. 20090017032 MAMMALIAN CX3C CHEMOKINE ANTIBODIES - Nucleic acids encoding a new family of chemokines the CX3C family from a mammal 01-15-2009
118. 20090017018 USES OF MAMMALIAN CYTOKINE: RELATED REAGENTS 01-15-2009
119. 20090005559 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES 01-01-2009
120. 20090004649 EVERNINOMICIN BIOSYNTHETIC GENES - This invention is directed to nucleic acids which encode the proteins that direct the synthesis of the orthosomycin 01-01-2009
121. 20080319039 UNIT DOSAGE FORMS OF TEMOZOLOMIDE - This invention relates to unit dosage forms of temozolomide 12-25-2008
122. 20080312218 FUSED TETRACYCLIC MGLUR1 ANTAGONISTS AS THERAPEUTIC AGENTS 12-18-2008
123. 20080311623 Plasmid system for multigene expression - plasmid system which facilitates the construction of a single amplifiable plasmid that 12-18-2008
124. 20080299186 COATINGS FOR APPLYING SUBSTANCES ONTO SUBSTRATE CARRIER 12-04-2008
125. 20080293734 PHARMACEUTICAL COMPOSITIONS - Disclosed are useful pharmaceutical compositions 11-27-2008
126. 20080292589 NOVEL HETEROCYCLIC SUBSTITUTED PYRIDINE OR PHENYL COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY 11-27-2008
127. 20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand 11-13-2008
128. 20080271340 Gel Insole - insole for insertion into footwear comprising a forefoot portion a midfoot portion and a heel portion 11-06-2008
129. 20080269273 TREATMENT METHOD - Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition or 10-30-2008
130. 20080262017 Sugar-Free Storage-Stable Antihistaminic Syrups 10-23-2008
131. 20080261942 COMBINATIONS OF BILE ACID SEQUESTRANT(S) AND STEROL ABSORPTION INHIBITOR(S) AND TREATMENTS FOR VASCULAR INDICATIONS 10-23-2008
132. 20080255156 ADENOSINE A2A RECEPTOR ANTAGONISTS - Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein: X 10-16-2008
133. 20080254128 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same 10-16-2008
134. 20080253970 Stable Pharmaceutical Drug Products - Various aspects of the present invention provide for methods of manufacturing a pharmaceutical drug product 10-16-2008
135. 20080234248 Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof 09-25-2008
136. 20080234236 REDUCTION OF ADVERSE EVENTS AFTER PERCUTANEOUS INTERVENTION BY USE OF A THROMBIN RECEPTOR ANTAGONIST 09-25-2008
137. 20080227156 NUCLEIC ACIDS ENCODING NEUTRALIZING GDF8 EPITOPE-BASED PEPTIDES AND FUSION PROTEINS 09-18-2008
138. 20080226618 HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS 09-18-2008
139. 20080220528 HIV GENE CLONING STRATEGY - methods for cloning Human Immunodeficiency Virus genes, in particular HIV envelope genes 09-11-2008
140. 20080214575 PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS 09-04-2008
141. 20080213192 AEROSOL LOTION FORMULATIONS - Non-foaming aqueous emulsion compositions 09-04-2008
142. 20080210770 DEVICE FOR MITIGATING ODOR IN AN ARTICLE OF CLOTHING OR FOOTWEAR 09-04-2008
143. 20080207585 Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof 08-28-2008
144. 20080206346 PREPARATION OF POWDER AGGLOMERATES - producing an agglomerate of drug and solid binder 08-28-2008
145. 20080200446 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof 08-21-2008
146. 20080200445 Heterocyclic aspartyl protease inhibitors 08-21-2008
147. 20080199477 HUMAN RECEPTOR PROTEINS; RELATED REAGENTS AND METHODS 08-21-2008
148. 20080199460 Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease 08-21-2008
149. 20080199447 CATALYTIC DOMAIN OF ADAM33 AND METHODS OF USE THEREOF 08-21-2008